Computational and experimental assessment of key interdomain residues controlling the fold‐switch of RfaH
Protein Science · 2025
DOI: 10.1002/pro.70202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2025. Verfasst von Cyndi Tabilo-Agurto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile,…. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Trans-Activators, Escherichia coli, Peptide Elongation Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Agencia Nacional de Investigación y Desarrollo, NIH HHS.
Abstract (Originalsprache)
Escherichia coli RfaH, a member of the universally conserved NusG family of transcription factors, regulates its function by undergoing a structural rearrangement of its C‐terminal domain (CTD) upon recruitment to RNA polymerase (RNAP) paused at the DNA signal known as operon polarity suppressor ( ops ) element. While it is known that the fold‐switch of RfaH CTD from an α‐helical hairpin (autoinhibited state) into a β‐barrel (active state) is controlled by interactions between the N‐terminal domain (NTD) and CTD, which are broken apart upon NTD binding to RNAP, a comprehensive analysis of residues that stabilize the autoinhibited state is lacking. Here, we utilize a combination of molecular dynamics (MD), protein structure prediction, and in vivo functional assays as a workflow to determine key interdomain (ID) residues controlling the fold‐switch of RfaH. First, MD simulations employing structure‐based models identified eight CTD residues with high ID contact probability, therefore expected to play a crucial role in stabilizing the autoinhibited state of RfaH. In silico alanine scanning mutagenesis followed by structure prediction using AlphaFold2 showed that four of these mutants (F126A, E136A, R138A, and L142A) led to several models with mixed α/β secondary structure for the CTD in comparison to the known fold‐switching mutant E48A. Lastly, experimental alanine scanning mutagenesis and RfaH‐dependent in vivo luminescence assays confirmed that I129 and L142 contribute to the stabilization of the autoinhibited state. These results deepen our understanding of the fold‐switch of RfaH, with tools that are applicable to other metamorphic proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
- ANID, Millennium Science Initiative Program, Millennium Institute for Integrative Biology (iBio), Santiago, Chile.
- Department of Microbiology and Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: César A Ramírez-Sarmiento
Förderung
- NIGMS NIH HHS
- Agencia Nacional de Investigación y Desarrollo
- NIH HHS
- National Institutes of Health
Zitieren
APA
Tabilo-Agurto, C., Reyes, J., Artsimovitch, I., & Ramírez-Sarmiento, C. A. (2025). Computational and experimental assessment of key interdomain residues controlling the fold‐switch of RfaH. Protein Science. https://doi.org/10.1002/pro.70202
Vancouver
Tabilo-Agurto C, Reyes J, Artsimovitch I, Ramírez-Sarmiento CA. Computational and experimental assessment of key interdomain residues controlling the fold‐switch of RfaH. Protein Science. 2025. doi:10.1002/pro.70202
BibTeX
@article{TabiloAgurto2025,
author = {Tabilo-Agurto, Cyndi and Reyes, Javiera and Artsimovitch, Irina and Ramírez-Sarmiento, César A},
title = {Computational and experimental assessment of key interdomain residues controlling the fold‐switch of RfaH},
journal = {Protein Science},
year = {2025},
doi = {10.1002/pro.70202}
}
EUVIMED